Groundbreaking stabilization & delivery enabling technology
for your microbial and biological products
From live attenuated viral and bacterial vaccines to therapeutic proteins, blood components, and highly reactive and unstable pharmaceuticals, UST has a long track record of applying novel technologies for the stabilization of labile biological drugs suitable for conventional delivery or formulated for mucosal delivery without reconstitution.
The human body is home to trillions of microorganisms including bacteria, viruses, and fungi. As we learn more about the potential microbiome modulating microbes have on human health, it is clear product companies need an effective alternative to lyophilization to Produce beneficial
bacteria without losses in therapeutic value during manufacture and subsequent storage.
Ensuring the efficacy, stability, and commercial viability of microbial products and their metabolites in real world conditions are among the biggest challenges in agriculture. To reduce the environmental impact of farming while enhancing crop production, growers must see improvements in yield, longer shelf life, and compatibility with agrochemicals.
We are committed to working with our partners to help them develop innovative solutions for protecting and enhancing animal health and nutrition. Our proprietary stabilization and delivery enabling technologies are helping our partners enhance their microbial and biologic products by resolving significant challenges related to formulation and development allowing production at scale, long shelf life, stability, and protection in real world conditions.
Universal Stabilization Technologies, Inc. ("UST") is a San Diego-based biopharmaceutical R&D company and provider of leading stabilization and delivery enabling technologies with higher yields and at higher storage temperatures than currently possible. UST’s proprietary process allows the cost-effective stabilization and delivery of fragile biologicals from biomedical to agricultural applications during long-term storage, transport, and distribution. UST also develops novel methods for mucosal and transdermal administration of labile biologicals.